Arrowhead Research (ARWR) Stock: Buy, Sell, or Hold?
ARWR - Arrowhead Research Corporation
$64.41
-0.38 (-0.59%)
▼
5d:
-2.29%
30d:
-24.55%
90d:
-25.58%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 24, 2026
Get Alerted When ARWR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ARWR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ARWR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ARWR is currently trading at $64.41, which is considered oversold relative to its 30-day fair value range of $68.02 to $86.27.
Technical Outlook: Technically, ARWR is in a uptrend. The price is currently testing key support at $63.99. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ARWR scores 73/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $107.23 (+65.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARWR is in a uptrend. The price is currently testing key support at $63.99. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ARWR scores 73/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $107.23 (+65.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$68.02 -
$86.27
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
Protect Your Profits
Holding ARWR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (73/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 65.5% below Wall St target ($107.23)
- CAUTION: Bottoming setup, but lagging the sector by 39% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$68.02 -
$86.27
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$63.99
Resistance Level
$72.49
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.14
Wall Street Target
$107.23
(+65.5%)
Revenue Growth (YoY)
171.0%
Earnings Growth (YoY)
9.8%
Profit Margin
-47.8%
Share & Embed Analysis
Last updated: October 02, 2026 3:32 PM ET
Data refreshes hourly during market hours. Next update: 4:32 PM
Data refreshes hourly during market hours. Next update: 4:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARWR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
James C Hamilton
SELL
10000 shares
2026-04-23
Daniel Joseph Apel
SELL
13095 shares
2026-04-22
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$371 | 49 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$199 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 63 BUY |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$310 | 66 BUY |
Advanced ARWR Option Strategies
Professional options setups generated by AI based on today's ARWR price and gamma walls.
